UK's Belluscura sinks after withdrawing 2025 forecast on US-China trade war

Shares of medical device maker Belluscura BELLB.L plunge as much as 50.4% to record low of 0.62p

Co withdraws its forecast for 2025 due to the latest U.S. tariffs imposed on China

Co says "significant proportion" of its portable oxygen concentrators, raw materials and component parts are currently manufactured in China, which now faces 54% tariffs on goods imported into the U.S

8.7 million shares traded, compared to 30-day avg of 1.9 million

Stock's YTD decline deepens to about 93%